Thailand buys 50,000 courses of Pfizer anti-viral drug Paxlovid


BANGKOK (The Nation/Asia News Network): The Medical Services Department on Thursday (March 24) signed a contract to purchase 50,000 treatment courses of Paxlovid drug with Pfizer Thailand for Covid-19 patients in risk groups.

Department director-general Somsak Akkasilp took part in the online contract signing with Deborah Seifert, country manager of Pfizer Thailand and Indochina.

The Star 6.6 DEAL: 35% OFF Digital Access

Monthly Plan

RM 13.90/month

RM 9.04/month

Billed as RM 9.04 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Thailand , covid-19 , anti-viral , Pfizer , drug , paxlovid

Next In Aseanplus News

China issues yellow rainstorm warning and orange mountain torrent alerts
North Korea nuclear programme 'absolutely non-negotiable': leader's sister
Ballot shortage sparks protest
Prosecutors office to hold internal probe after rape claim
Hotel chain cites US sanctions, confirms exit from Cuba
Surviving on chocolate and ice
Cockroach revolt over exam chaos
Cave rescue for two halted
Worker: ‘Chained’ patient was among fire victims
Going solo: Bersama will contest state polls alone, says Rafizi

Others Also Read